Quick Answer
ORAMED PHARMACEUTICALS INC. reported Net Income of $64.05 million for fiscal year 2025.
ORAMED PHARMACEUTICALS INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $64.05M | +436.0% |
| 2024 | -$19.06M | -474.6% |
| 2023 | $5.09M | +113.9% |
| 2022 | -$36.56M | -59.0% |
| 2021 | -$22.99M | -99.7% |
| 2020 | -$11.51M | +19.8% |
| 2019 | -$14.36M | -12.8% |
| 2018 | -$12.73M | -21.4% |
| 2017 | -$10.48M | +4.4% |
| 2016 | -$10.96M | -51.6% |
| 2015 | -$7.23M | -27.0% |
| 2014 | -$5.70M | -234.6% |
| 2013 | $4.23M | +226.6% |
| 2012 | -$3.34M | -114.2% |
| 2011 | -$1.56M | +47.6% |
| 2010 | -$2.98M | -7.9% |
| 2009 | -$2.76M | +0.3% |
| 2008 | -$2.77M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $48.40M | +346.7% | +264.2% |
| June 30, 2025 | $13.29M | +44.2% | +273.9% |
| March 31, 2025 | -$7.64M | -597.5% | +61.0% |
| September 30, 2024 | -$19.62M | -508.9% | -313.0% |
| June 30, 2024 | $9.21M | +871.5% | +499.7% |
| March 31, 2024 | $1.54M | +145.2% | +147.7% |
| September 30, 2023 | -$3.22M | +54.4% | -169.8% |
| June 30, 2023 | -$1.19M | +88.7% | +64.8% |
- ORAMED PHARMACEUTICALS INC. showed an increase of +436.0% in Net Income compared to the prior fiscal year.
- Over the 2008–2025 period, ORAMED PHARMACEUTICALS INC.’s net income has grown by 2412.9% (from -$2.77 million to $64.05 million).
- The most recent figure is from ORAMED PHARMACEUTICALS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: